Jeffrey Robert Ajer, Director at NEKTAR THERAPEUTICS (NKTR), sold 4,359 shares at $0.69 ($3K) on 2023-09-18, disclosed to the SEC on 2023-09-20.
Seasonal sale ($3k) by Director — this insider has traded NKTR in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| BMRN | SELL | 2023-08-17 | $450K | — | Filing → |
| BMRN | SELL | 2023-01-27 | $11.3M | — | Filing → |
| BMRN | SELL | 2022-11-04 | $258K | — | Filing → |